Nebivolol Hydrochloride

CHEMBL1201731 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

441.9 g/mol

LogP

—

Phase

4

This is the hydrochloride salt form of nebivolol used for the same heart failure and hypertension indications.

Moleküler Ağırlık

441,9000 g/mol

TPSA

71,00 Å²

Terapötik Alanlar

Glaucoma Cardiovascular Disease Osteoporosis Chronic Obstructive Pulmonary Disease Chronic Kidney Disease Stroke Lymphoma Type 2 Diabetes Hypertension Breast Cancer Heart Failure Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1

InChI

InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H

Molecular Formula

C22H26ClF2NO4

HBD / HBA

4 / 7

Döndürülebilir Bağlar

6

Ağır Atomlar

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This is the hydrochloride salt form of nebivolol used for the same heart failure and hypertension indications.

Yes, Nebivolol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201731. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24866733. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Nebivolol Hydrochloride PillFYI'da

Yapı

Hızlı Veriler

Formül: C22H26ClF2NO4
Eş Anlamlılar: 2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.